It is unclear if 17p13.3 deletion predisposes cells to cancer though isolated cases of malignancy has been reported in patients of Miller-Dieker syndrome and it is therefore possible that loss of RPA checkpoint function is compensated by hSSB1/2-INTS3 pathway (56). The gene discussed is RPA1; the disease is Miller-Dieker lissencephaly syndrome.